Lilly Just Announced Infectious Disease Deals Diversification
Eli Lilly is shaking up its growth plan by expanding beyond obesity with new infectious disease initiatives. This art...
Bear markets test retirement portfolios. This piece explains how risk parity may influence drawdowns and resilience, plus practical steps for retirees.
28,208 articlesEli Lilly is shaking up its growth plan by expanding beyond obesity with new infectious disease initiatives. This art...
On a volatile trading day, SpaceX headlines helped ease Nasdaq losses while the Dow pressed onward. Dive into what sp...
Autonomous AI agents are moving beyond chatbots to do complex tasks. This article explains why the agentic market cou...
Trust Wallet has unveiled automatic Address Poisoning Protection to shield users from spoofing attacks. The feature a...
A single AI stock could outperform the rest on Nasdaq by the end of 2026. This article breaks down why that might hap...
P3 Health's Q1 2026 results set the stage for an important year in health services. This analysis breaks down the ear...
Two pharma giants compete for your portfolio's income. This guide weighs yields, safety, and long-term risks to answe...
In May, iren limited rallied almost 40% as investors priced in AI growth, earnings signals, and a new Nvidia partners...
Nvidia is betting on a future where it sells complete AI production lines, not just chips. This shift could redefine ...
In Q1 2026, Tepper’s Appaloosa slashed its Microsoft stake by about 82%, while Bill Ackman’s Pershing Square bought r...
An insider at Rackspace Technology recently disclosed a significant stock sale. This article explains what that means...
Adobe stock is back in the spotlight as AI reshapes software. This guide explains what drives the buzz, how Adobe ear...